A detailed history of Capital Research Global Investors transactions in Icon PLC stock. As of the latest transaction made, Capital Research Global Investors holds 2,200,417 shares of ICLR stock, worth $715 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
2,200,417
Previous 2,553,673 13.83%
Holding current value
$715 Million
Previous $723 Million 2.26%
% of portfolio
0.17%
Previous 0.18%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$247.84 - $340.0 $87.6 Million - $120 Million
-353,256 Reduced 13.83%
2,200,417 $739 Million
Q4 2023

Feb 13, 2024

BUY
$222.83 - $285.76 $118 Million - $152 Million
530,548 Added 26.22%
2,553,673 $723 Million
Q3 2023

Nov 13, 2023

SELL
$236.44 - $265.62 $14 Million - $15.8 Million
-59,384 Reduced 2.85%
2,023,125 $498 Million
Q2 2023

Aug 11, 2023

BUY
$183.12 - $250.2 $62.3 Million - $85.1 Million
340,035 Added 19.51%
2,082,509 $521 Million
Q1 2023

May 15, 2023

BUY
$193.59 - $245.33 $157 Million - $199 Million
812,713 Added 87.41%
1,742,474 $372 Million
Q4 2022

Feb 14, 2023

BUY
$173.9 - $224.8 $6.48 Million - $8.38 Million
37,268 Added 4.18%
929,761 $181 Million
Q3 2022

Nov 14, 2022

SELL
$183.25 - $247.5 $7,330 - $9,900
-40 Reduced -0.0%
892,493 $164 Million
Q2 2022

Aug 15, 2022

BUY
$197.3 - $261.32 $32.8 Million - $43.4 Million
166,136 Added 22.87%
892,533 $193 Million
Q1 2022

May 16, 2022

SELL
$216.09 - $296.03 $41.8 Million - $57.3 Million
-193,555 Reduced 21.04%
726,397 $177 Million
Q4 2021

Feb 14, 2022

BUY
$258.11 - $309.7 $51,880 - $62,249
201 Added 0.02%
919,952 $285 Million
Q3 2021

Nov 15, 2021

BUY
$208.53 - $283.04 $192 Million - $260 Million
919,751 New
919,751 $241 Million

Others Institutions Holding ICLR

About ICON PLC


  • Ticker ICLR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 81,526,600
  • Market Cap $26.5B
  • Description
  • ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...
More about ICLR
Track This Portfolio

Track Capital Research Global Investors Portfolio

Follow Capital Research Global Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.